Minerva Neurosciences, Inc.NERVNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank10
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P10
Near historical low
vs 5Y Ago
-2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-53.66%
Q3 2025-42.80%
Q2 20250.00%
Q1 20250.00%
Q4 2024-18.72%
Q3 2024-10.54%
Q2 202435.39%
Q1 2024-1.72%
Q4 2023-24.66%
Q3 2023-24.13%
Q2 2023-3254.98%
Q1 202397.20%
Q4 202256.71%
Q3 2022-83.56%
Q2 202210.60%
Q1 2022-20.18%
Q4 202143.98%
Q3 2021-45.60%
Q2 2021-13.56%
Q1 202127.12%
Q4 202027.48%
Q3 2020-30.08%
Q2 202017.53%
Q1 202035.11%
Q4 2019-48.94%
Q3 20196.01%
Q2 2019-5.51%
Q1 20192.03%
Q4 20181.85%
Q3 201811.05%
Q2 2018-2.69%
Q1 2018-22.67%
Q4 2017-135.80%
Q3 2017463.72%
Q2 2017-13.23%
Q1 201732.29%
Q4 2016-91.73%
Q3 201623.10%
Q2 2016-0.09%
Q1 20168.38%